18 June Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic
Posted at 18: 52h
in COVID-19
S. Kwiatkowski, D. Borowski, A. Kajdy, LC Poon, W. Rokita and M. Wielgos
ABSTRACT
To our knowledge, there is limited data to suggest that there is an association between prophylactic use of low-dose aspirin and increased risk of progression of SARS-CoV-2 infection.
In our opinion, during the COVID-19 pandemic, it remains essential to provide first trimester screening for placental complications and prescribe low-dose aspirin in women identified as being at high risk for preeclampsia and fetal growth restriction.
Based on the current knowledge of the epidemiological situation, the benefits of preventing placental complications outweigh the potential risks of adverse outcomes related to the use of low-dose aspirin in patients with SARS-CoV-2 infection.